Clinical Trial Update: Efficacy, Tolerability and Acceptability of Biktarvy by TPLWH [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on the efficacy, tolerability, and acceptability of Biktarvy in people living with HIV, which has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• BIKTARVY (BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE)

Snippet

Sponsor: Chelsea and Westminster NHS Foundation Trust | Conditions: Human Immunodeficiency Virus | Phase 4 | Status: TERMINATED